Bench:Jyoti Singh
185 IP cases indexed. Covers patent, trademark, copyright matters.
Cases Presided Over
185 cases indexed | Page 1 of 7
AstraZeneca AB & Anr. v.Intas Pharmaceuticals Limited
AstraZeneca AB and another plaintiff filed a patent infringement suit against Intas Pharmaceuticals Limited concerning Indian Patent Nos. 205147 and 235625. During the pendency of the suit, the parties arrived at an amicable settlement and entered into a Settlement Agreement. The defendant agreed to withdraw its counter-claim of invalidity and waive the cost of Rs. 5 lakhs previously awarded in its favour. The court disposed of the suit in terms of the settlement and granted refund of court fees to the plaintiffs.
AstraZeneca AB & Anr. v.USV Private Limited
AstraZeneca AB sued USV Private Limited for permanent injunction restraining infringement of Indian Patent Nos. 205147 and 235625. During the pendency of the suit, the parties arrived at an amicable settlement and entered into a Settlement Agreement. Under the settlement, USV agreed to withdraw its invalidity counterclaim and waive the cost of Rs. 5 lakhs previously awarded in its favour in FAO(OS)(COMM) No. 157/2020. The Delhi High Court decreed the suit in terms of the settlement, making the Settlement Agreement part of the decree.
Asustek Computer Inc & Anr. v.Nokia Technologies Oy & Anr.
Asustek Computer Inc filed revocation petitions under Section 64 of the Patents Act, 1970 against Nokia Technologies Oy's Indian patents IN'056 and IN'246, while Nokia had filed a separate infringement suit (CS(COMM) 643/2025) against Asustek alleging infringement of patents IN'507 and IN'105. During the pendency of proceedings, the parties entered into a Patent License Agreement adjustable through arbitration to settle their disputes. The Delhi High Court allowed Asustek to withdraw the revocation petitions and disposed of them with liberty to reinstitute proceedings in accordance with law if so required.
Novartis AG & Anr. v.Torrent Pharmaceuticals Limited
Novartis AG sued Torrent Pharmaceuticals for infringement of Indian Patent No. 275655 covering the anti-cancer drug Dabrafenib. Torrent accepted summons and voluntarily undertook not to manufacture, launch, import, export, or deal in any Dabrafenib-containing API or formulation during the patent's validity. The Delhi High Court accepted the undertaking as part of the decree, effectively granting Novartis the relief of a permanent injunction without contest, while preserving Torrent's rights under Section 107A of the Patents Act to use the compound for research purposes.
Manash Lifestyle Private Limited v.Wella International Operations Switzerland Sarl & Anr.
Manash Lifestyle Private Limited filed a petition under Section 57 of the Trade Marks Act, 1999 seeking rectification/cancellation of the trademark 'ULTIME SMOOTH' registered in Class 03 in favour of Wella International Operations Switzerland Sarl. The parties entered into a Settlement Agreement dated 17.07.2026, which the court found lawful. Pursuant to the settlement, the court allowed the petition and directed the Registrar of Trade Marks to remove the mark from the Register to maintain its purity.
Incyte Holdings Corporation & Ors. v.Macleods Pharmaceuticals Ltd
Incyte Holdings sued Macleods Pharmaceuticals for alleged infringement of Indian Patent No. 269841 covering the novel compound Ruxolitinib, used in treating myelofibrosis and polycythemia vera. Macleods had listed Ruxolitinib products as 'Under Development' in its US CTD Product List and was offering the API for sale on Pharmacompass. The defendant gave an undertaking not to commercially manufacture, launch, import, export, or deal in any product containing Ruxolitinib during the patent's validity (expiring 12.12.2026), and the suit was disposed of with the undertaking binding the defendant while preserving its Section 107A research rights.
Nature Coatings Inc v.The Controller General of Patents Designs and Trade Marks
Nature Coatings Inc has filed an appeal under Section 117A of the Indian Patents Act, 1970 before the Delhi High Court challenging the order dated 16.04.2026 refusing grant of patent for Application No. 202227024750. The court allowed the appellant's application for exemption and granted three weeks' time to place on record the apostilled Power of Attorney. Notice was issued to the Controller General of Patents, Designs and Trade Marks, who accepted notice through counsel, with timelines set for filing reply and rejoinder.
Opella Healthcare Group v.Pureca Laboratories Pvt Ltd
Opella Healthcare Group, part of the Sanofi Group and registered proprietor of the well-known pharmaceutical trademark PHENSEDYL (used in India since 1995), sued Pureca Laboratories for adopting the deceptively similar mark PHENSERYL along with a copycat trade dress for identical cough syrup products. The Defendant's trademark registration (No. 3791026) and copyright registration (No. A-130319/2019) had already been cancelled by the Court in prior rectification proceedings. With the Defendant failing to appear and being set ex parte, the Court granted summary judgment under Order XIII-A of the Commercial Courts Act, holding that the Defendant had no real prospect of defending the claims and that the Plaintiff had established both trademark infringement under Section 29 of the Trade Marks Act, 1999 and passing off.
Asustek Computer Inc & Anr. v.Nokia Technologies Oy & Anr.
Asustek Computer Inc filed a patent revocation petition under Section 64 of the Patents Act, 1970 seeking revocation of Nokia Technologies Oy's Indian Patent IN'206. Nokia had separately filed CS(COMM) 643/2025 alleging infringement of patent nos. 424507 and 338105. During pendency, the parties entered into a Patent License Agreement adjustable through arbitration to settle their disputes. Consequently, the Delhi High Court permitted withdrawal of the revocation petition with liberty to re-institute proceedings if so required.
Ads Spirits Pvt. Ltd. v.The Registrar of Trade Marks
Ads Spirits Pvt. Ltd., part of the ADS Group of liquor companies, appealed under Section 91 of the Trade Marks Act, 1999 against the Registrar's refusal to register the mark 'OFFER' in Class 33 for alcoholic beverages. The Registrar had refused registration under Section 9(1)(a) on the ground that the mark was a common/personal/geographical name and non-distinctive. The Delhi High Court held that the Registrar applied the wrong test, since Section 9(1)(a) bars marks devoid of distinctive character but does not require uniqueness, novelty, or inventiveness as a precondition for registration. The court found the impugned order to be non-speaking and perverse, showing complete non-application of mind, and quashed it while directing reconsideration.
Abbvie Inc v.Controller General Of Patents, Designs, Trademarks And Geographical Indications & Ors.
Abbvie Inc has filed an appeal against the Controller General Of Patents, Designs, Trademarks And Geographical Indications, challenging an order dated 27.04.2026 related to Indian Patent Application No. 4759/DELNP/2012. The Delhi High Court has issued notice to the respondents and allowed the appellant to file a lengthy list of dates and the synopsis. The court has also directed the parties to file written submissions before the next date of hearing.
Havells India Limited & Anr. v.Havai Home Products Pvt. Ltd. & Ors.
Havells India Limited, a well-known FMEG company, sued Havai Home Products Pvt. Ltd. for trademark infringement and passing off, alleging that the defendants' mark 'HAVAI' was deceptively similar to their well-known trademark 'HAVELLS'. The court found that the defendants had cleverly modified the letter 'L' to 'I' to create phonetic and visual similarity, with the intent to encash on Havells' reputation. The court recognized HAVELLS as a well-known mark based on its extensive use since 1955, global presence across 60+ countries, and substantial sales and advertising expenditure. An ad interim injunction was granted restraining the defendants from using the impugned marks during the pendency of the suit.
Torrent Pharmaceuticals Ltd v.Astrazeneca Ab And Ors
The Delhi High Court allowed Torrent Pharmaceuticals Ltd to withdraw its petition for revocation of AstraZeneca AB's patent IN235625. The petition was withdrawn due to a settlement between the parties. The court disposed of the petition and pending applications. The case highlights the importance of settlement in resolving intellectual property disputes. The patent in question was related to a pharmaceutical invention.
Himalaya Global Holdings Ltd & Anr v.Awadh Bihari Badal Proprietor Of Aloe Care Arogya Life & Anr
The Delhi High Court granted an ex parte ad interim injunction in favor of Himalaya Global Holdings Ltd, restraining the defendant from using the mark 'Liv-22' which is deceptively similar to the plaintiff's registered trademark 'Liv.52'. The court found that the plaintiff had made out a prima facie case for grant of interim injunction and that the balance of convenience lay in favor of the plaintiff. The defendant's use of the mark 'Liv-22' was likely to cause irreparable harm to the plaintiff's goodwill and reputation.
Emcure Pharmaceuticals Limited v.Orziva Healthcare Private Limited & Ors
Emcure Pharmaceuticals Limited filed a lawsuit against Orziva Healthcare Private Limited & Ors for trademark infringement and passing off. The court granted an injunction restraining the Defendants from manufacturing and selling products under the impugned marks ORZIFER-XT, which are deceptively similar to Emcure's trademarks OROFER and OROFER-XT. The court found that Emcure has established a strong reputation and goodwill in its trademarks and that the Defendants' actions are likely to cause irreparable damage to Emcure's goodwill and reputation.
Fortune Marketing Private Limited v.Gujarat Pesticides & Ors.
The Delhi High Court revoked the impugned copyright registration of the artistic work/label/packaging titled ZOOOK in favor of Gujarat Pesticides & Ors. due to procedural flaws. The court found that the grant of copyright registration was procedurally flawed and deserved to be revoked. The original application filed by Respondent No.1 is revived for fresh consideration by Respondent No.2. The court has not expressed any opinion on the merits of the case.
Grm Foodkraft Pvt Ltd And Anr v.Ks Agro Impex And Anr
The Delhi High Court granted an injunction in favor of Grm Foodkraft Pvt Ltd, restraining Ks Agro Impex from selling Golden Sella Basmati Rice in packaging that is deceptively similar to the plaintiff's trade dress. The court found that the defendant's packaging was likely to cause confusion among consumers and harm the plaintiff's goodwill. The defendant is allowed to continue selling Golden Sella Basmati Rice using distinct and non-deceptive packaging. The case highlights the importance of protecting intellectual property rights, particularly in the FMCG sector.
Danone Asia Pacific Holdings Pte. Ltd v.Manju Kumari Wife Of Sudhir Suman & Anr
The Delhi High Court allowed a petition filed by Danone Asia Pacific Holdings Pte. Ltd to cancel the registration of the trademark PROTRILEX, which was found to be deceptively similar to Danone's registered trademark PROTINEX. The court held that the registration of PROTRILEX was in violation of Section 11(1)(b) of the Trade Marks Act, 1999. The court directed the Registrar of Trade Marks to rectify the register within four weeks.
Glaxosmithkline Pharmaceuticals Limited v.Walter Healthcare Private Limited And Anr
The Delhi High Court declared the trademark CALPOL as a well-known trademark in terms of the Trade Marks Act, 1999, due to its long-standing reputation and extensive use in India. The court recognized the significant commercial presence and recognition of the mark CALPOL in the field of medicine and pharmaceutical products. The defendant was restrained from using the WALPOL mark, which was deemed deceptively similar to the CALPOL mark.
M/S Balar Marketing Pvt. Ltd v.Lakha Ram Sharma
The Delhi High Court dismissed a petition filed by M/S Balar Marketing Pvt. Ltd challenging an order of the Trial Court that refused to allow the examination of an additional witness. The case involves a trademark dispute over the mark 'KUNDAN' used for electric goods. The petitioner had filed multiple suits against the respondent, including one for trademark infringement and another for passing off. The court held that the petitioner's application to examine the additional witness was inconsequential and did not warrant interference.
Asustek Computer Inc v.Nokia Technologies Oy
The Delhi High Court heard petitions filed by Asustek Computer Inc seeking the revocation and removal of two specific Indian Patents (Nos. 381056 and 320467) from the register. The court also addressed several interlocutory applications regarding document division and exemptions.
Asustek Computer Inc v.Nokia Technologies Oy
The petitioners, Asustek Computer Inc, filed petitions seeking the revocation and removal of two specific Indian Patents (Nos. 381056 and 320467) from the patent register. The court also addressed several interlocutory applications concerning exemptions and procedural matters.
Alkem Laboratories Limited v.Novartis Ag & Anr.
Alkem Laboratories Limited filed a petition seeking the revocation of Indian Patent IN414518 and its removal from the Register of Patents. The respondent submitted that the patent in question had already been revoked, which was acknowledged by the petitioner's counsel.
ITC Limited v.Philip Morris Products S.A.
ITC Limited appealed against an order that dismissed its post-grant opposition to Indian Patent No. 319780. The appeal challenged the dismissal on grounds that the impugned order was non-speaking and failed to consider crucial reply evidence and documents filed by ITC under Rule 59 of the Patents Rules, 2003. The Court found that the Controller had ignored categorical directions regarding these submissions.
Apriori Inc v.The Assistant Controller Of Patents And Designs
Apriori Inc filed an appeal before the Delhi High Court challenging the Assistant Controller's decision dated 15.12.2025, which refused to grant a patent for Indian Patent Application No. 202017008435. The court issued notice to the respondent and set a date for returnable hearing.
Novartis Ag & Anr v.Controller General Of Patents, Designs, Trademarks And Geographical Indications & Ors.
Petitioners filed a writ petition seeking directions to expedite the consideration of their Indian Patent Application No. 1014/DELNP/2011, which had been pending for over 15 years despite multiple pre-grant oppositions being filed. The Court noted the unacceptable delay and directed the Respondents to decide the application and all related oppositions as expeditiously as possible within four months.
Emd Millipore Corporation v.Assistant Controller Of Patents And Designs
Emd Millipore Corporation appealed the Assistant Controller's order refusing to grant a patent for a method of integrity testing a liquid sterilizing grade filter due to lack of inventive step. The court allowed the amendment sought by the appellant and partially set aside the refusal order, remanding the matter back to the Respondent for fresh examination.
Sk Bioscience Co Ltd v.Assistant Controller Of Patents And Designs
Sk Bioscience Co Ltd appealed against the Assistant Controller's order rejecting the grant of a patent application. The Appellant subsequently sought to withdraw the appeal, which was accepted by the Respondent.
Pps International v.Subhajit Goswami And Another
The petitioner filed an application seeking permission to lead expert evidence regarding the potential revocation of an impugned patent under Section 64 of the Patents Act, 1970. The court allowed the application, permitting the Petitioner to file the necessary evidence affidavit.
Tak Technologies Private Limited v.Sagi Faifer & Anr.
Tak Technologies Private Limited filed a petition seeking the revocation of Indian Patent No. 477619 held by Mr. Sagi Faifer. The court issued notices and directed the respondent to file a reply within four weeks.
Facing a similar IP matter?
Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.